The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1-(((R)-1-acryloylpyrrolidin-2-yl)methyl)-5-(((S)-3,3-dimethylbutan-2-ylamino)methyl)-1H-benzo[d]imidazol-2(3H)-ylidene)-5-(difluoromethyl)thiophene-2-carboxamide ID: ALA4541397
Cas Number: 1575818-46-0
PubChem CID: 90044055
Product Number: P612926, Order Now?
Max Phase: Preclinical
Molecular Formula: C28H35F2N5O2S
Molecular Weight: 543.68
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1CCC[C@@H]1Cn1/c(=N/C(=O)c2ccc(C(F)F)s2)[nH]c2cc(CN[C@@H](C)C(C)(C)C)ccc21
Standard InChI: InChI=1S/C28H35F2N5O2S/c1-6-24(36)34-13-7-8-19(34)16-35-21-10-9-18(15-31-17(2)28(3,4)5)14-20(21)32-27(35)33-26(37)23-12-11-22(38-23)25(29)30/h6,9-12,14,17,19,25,31H,1,7-8,13,15-16H2,2-5H3,(H,32,33,37)/t17-,19+/m0/s1
Standard InChI Key: NXTKFBGDLDPFLB-PKOBYXMFSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
8.4965 -6.4715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4954 -7.2910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2034 -7.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2017 -6.0626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9103 -6.4679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9151 -7.2865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6951 -7.5349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1725 -6.8698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6874 -6.2104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9896 -6.8650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3941 -6.1549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2112 -6.1501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9813 -5.4496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6959 -6.8080 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.4716 -6.5509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4668 -5.7337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6881 -5.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1355 -7.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0549 -7.8405 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.8801 -6.6906 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.7887 -6.0630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0811 -6.4718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3733 -6.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6657 -6.4721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3731 -5.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9579 -6.0637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6659 -7.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9527 -6.8760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9521 -8.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4089 -8.9211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5955 -8.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2675 -9.5912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8780 -10.1345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5832 -9.7217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3315 -10.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4214 -10.8623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9900 -9.5661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7384 -9.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
15 18 1 0
18 19 1 0
18 20 1 0
1 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 1 6
24 26 1 0
24 27 1 0
24 28 1 0
7 29 1 0
30 29 1 6
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 30 1 0
34 35 1 0
35 36 2 0
35 37 1 0
37 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.68Molecular Weight (Monoisotopic): 543.2480AlogP: 5.41#Rotatable Bonds: 8Polar Surface Area: 82.49Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.32CX LogP: 5.07CX LogD: 3.16Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.37Np Likeness Score: -1.09
References 1. Tang G, Liu L, Wang X, Pan Z.. (2019) Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk)., 173 [PMID:30999237 ] [10.1016/j.ejmech.2019.03.055 ] 2. Wang X, Xue G, Pan Z.. (2020) Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)., 187 [PMID:31830635 ] [10.1016/j.ejmech.2019.111918 ]